Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Spot platinum has just surpassed the $1610.00/oz mark, now quoted at $1610.05/oz, down 0.80% on the day; Nymex platinum futures' main contract is now quoted at $1616.0/oz, down 0.99% on the day.

Spot platinum has just surpassed the $1610.00/oz mark, now quoted at $1610.05/oz, down 0.80% on the day; Nymex platinum futures' main contract is now quoted at $1616.0/oz, down 0.99% on the day.

智通财经智通财经2026/07/28 07:31
Show original
Spot platinum has just broken through the $1,610.00/ounce mark, currently quoted at $1,610.05/ounce, down 0.80% on the day; Nymex platinum futures main contract is currently quoted at $1,616.0/ounce, down 0.99% on the day;
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

On Monday, storage chip concept stocks generally rose, with SanDisk (SNDK.US) up by 6%.

智通财经2026/08/17 13:51
U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds

On August 17, AstraZeneca (AZN.US) and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 study of Enhertu (trastuzumab deruxtecan) as a monotherapy for first-line treatment of non-small cell lung cancer (NSCLC) has achieved highly positive results.

智通财经2026/08/17 12:56
AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds